Home
>
National Drug Code (NDC)
>
TRIZIVIR
TRIZIVIR - 0173-0691-00 - (abacavir sulfate, lamivudine, and zidovudine)
Drug Information of TRIZIVIR
| Product NDC: | 0173-0691 |
| Proprietary Name: | TRIZIVIR |
| Non Proprietary Name: | abacavir sulfate, lamivudine, and zidovudine |
| Active Ingredient(s): | 300; 150; 300 mg/1; mg/1; mg/1 & nbsp; abacavir sulfate, lamivudine, and zidovudine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TRIZIVIR
| Product NDC: | 0173-0691 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021205 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20001130 |
Package Information of TRIZIVIR
| Package NDC: | 0173-0691-00 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (0173-0691-00) |
NDC Information of TRIZIVIR
| NDC Code | 0173-0691-00 |
| Proprietary Name | TRIZIVIR |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (0173-0691-00) |
| Product NDC | 0173-0691 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | abacavir sulfate, lamivudine, and zidovudine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20001130 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE |
| Strength Number | 300; 150; 300 |
| Strength Unit | mg/1; mg/1; mg/1 |
| Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
